+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Asthma - Pipeline Insight, 2025 - Product Thumbnail Image

Asthma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Ataxia Telangiectasia- Pipeline Insight, 2025 - Product Thumbnail Image

Ataxia Telangiectasia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Atypical Hemolytic Uremic Syndrome (aHUS) - Pipeline Insight, 2025 - Product Thumbnail Image

Atypical Hemolytic Uremic Syndrome (aHUS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Autism Spectrum Disorder (ASD) - Pipeline Insight, 2025 - Product Thumbnail Image

Autism Spectrum Disorder (ASD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bacterial Conjunctivitis - Pipeline Insight, 2025 - Product Thumbnail Image

Bacterial Conjunctivitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bacterial Meningitis - Pipeline Insight, 2025 - Product Thumbnail Image

Bacterial Meningitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bacterial Skin Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Bacterial Skin Diseases - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Beta-thalassemia- Pipeline Insight, 2025 - Product Thumbnail Image

Beta-thalassemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
BK Virus (BKV) Infections - Pipeline Insight, 2025 - Product Thumbnail Image

BK Virus (BKV) Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bronchial Dysplasia - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchial Dysplasia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Calciphylaxis - Pipeline Insight, 2025 - Product Thumbnail Image

Calciphylaxis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cartilage Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Cartilage Diseases - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CART-related Neurotoxicity (NT) - Pipeline Insight, 2025 - Product Thumbnail Image

CART-related Neurotoxicity (NT) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cerebral Adrenoleukodystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Cerebral Adrenoleukodystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Progressive Multiple Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Progressive Multiple Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Chronic Renal/Kidney Transplant Rejection - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Renal/Kidney Transplant Rejection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more